山东药玻
(600529)
| 流通市值：133.32亿 | | | 总市值：133.32亿 |
| 流通股本：6.64亿 | | | 总股本：6.64亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 3,400,516,917.76 | 2,373,844,830.37 | 1,242,455,243.5 | 5,125,270,640.68 |
| 营业收入 | 3,400,516,917.76 | 2,373,844,830.37 | 1,242,455,243.5 | 5,125,270,640.68 |
| 二、营业总成本 | 2,707,149,986.22 | 1,901,614,186.9 | 982,600,179.31 | 4,013,019,482.72 |
| 营业成本 | 2,275,678,059.1 | 1,622,904,283.33 | 867,166,737.37 | 3,499,338,477.09 |
| 税金及附加 | 37,676,460.66 | 25,032,717.94 | 10,446,215.51 | 54,549,603.3 |
| 销售费用 | 77,801,911.18 | 45,138,736.06 | 20,893,173.48 | 129,736,903.09 |
| 管理费用 | 194,166,835.56 | 128,031,063.82 | 41,187,436.65 | 215,768,838.57 |
| 研发费用 | 138,496,841.02 | 95,674,626.79 | 49,680,967.32 | 151,763,172.77 |
| 财务费用 | -16,670,121.3 | -15,167,241.04 | -6,774,351.02 | -38,137,512.1 |
| 其中:利息费用 | 18,210.41 | 11,153.73 | 4,942.62 | 25,183.45 |
| 其中:利息收入 | 11,705,229.47 | 7,888,019.25 | 3,526,865.62 | 21,211,803.93 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 7,987,785.22 | 6,447,381.91 | 4,105,310.68 | 24,463,237.31 |
| 加:投资收益 | 13,355,985.71 | 7,227,203.39 | 3,986,280.22 | 11,633,529.78 |
| 资产处置收益 | 808,971.47 | 417,482.36 | 109.46 | 329,546.95 |
| 资产减值损失(新) | -80,911,051.13 | -48,839,146.75 | - | -61,157,836.83 |
| 信用减值损失(新) | -74,651.04 | -4,459,841.93 | -6,196,742.54 | -1,283,636.72 |
| 其他收益 | 17,332,606.13 | 11,068,719.24 | 5,089,395.49 | 26,524,819.35 |
| 四、营业利润 | 651,866,577.9 | 444,092,441.69 | 266,839,417.5 | 1,112,760,817.8 |
| 加:营业外收入 | 1,777,673.44 | 1,103,350.42 | 868,048.55 | 3,398,144.75 |
| 减:营业外支出 | 5,252,955.54 | 3,648,149.62 | 792,935.38 | 5,353,909.36 |
| 五、利润总额 | 648,391,295.8 | 441,547,642.49 | 266,914,530.67 | 1,110,805,053.19 |
| 减:所得税费用 | 105,937,637.43 | 70,406,020.49 | 43,285,095.79 | 167,813,747.78 |
| 六、净利润 | 542,453,658.37 | 371,141,622 | 223,629,434.88 | 942,991,305.41 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 542,453,658.37 | 371,141,622 | 223,629,434.88 | 942,991,305.41 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 542,453,658.37 | 371,141,622 | 223,629,434.88 | 942,991,305.41 |
| 扣除非经常损益后的净利润 | 515,879,178.99 | 354,997,295.64 | 214,187,271.01 | 903,572,504.05 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.82 | 0.56 | 0.34 | 1.42 |
| (二)稀释每股收益 | 0.82 | 0.56 | 0.34 | 1.42 |
| 九、综合收益总额 | 542,453,658.37 | 371,141,622 | 223,629,434.88 | 942,991,305.41 |
| 归属于母公司股东的综合收益总额 | 542,453,658.37 | 371,141,622 | 223,629,434.88 | 942,991,305.41 |
| 公告日期 | 2025-10-28 | 2025-08-26 | 2025-04-25 | 2025-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |